Last reviewed · How we verify
Oral arsenic Trioxide, ATRA and ascorbic acid — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Oral arsenic Trioxide, ATRA and ascorbic acid (Oral arsenic Trioxide, ATRA and ascorbic acid) — The University of Hong Kong.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral arsenic Trioxide, ATRA and ascorbic acid TARGET | Oral arsenic Trioxide, ATRA and ascorbic acid | The University of Hong Kong | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral arsenic Trioxide, ATRA and ascorbic acid CI watch — RSS
- Oral arsenic Trioxide, ATRA and ascorbic acid CI watch — Atom
- Oral arsenic Trioxide, ATRA and ascorbic acid CI watch — JSON
- Oral arsenic Trioxide, ATRA and ascorbic acid alone — RSS
Cite this brief
Drug Landscape (2026). Oral arsenic Trioxide, ATRA and ascorbic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-arsenic-trioxide-atra-and-ascorbic-acid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab